Top

Published in:

01-09-2013 | Original Article

GreenLight HPS 120-W laser photoselective vaporization of the prostate as early therapy for acute urinary retention in advanced prostate cancer patients

Authors: Dong Chen, Boxin Xue, Yuxi Shan, Dongrong Yang, Chuanyang Sun, Jie Gao

Published in: Lasers in Medical Science | Issue 5/2013

Abstract

We evaluate the safety, efficacy, and oncological outcomes of early palliative photoselective vaporization of the prostate (PVP) by GreenLight high-performance system (HPS) 120-W laser in patients with acute urinary retention (AUR) induced by advanced prostate cancer (PCa). A total of 39 advanced PCa patients with AUR who underwent PVP were enrolled in this retrospective study. Baseline parameters, perioperative, and postoperative complications were reviewed. The functional outcomes were evaluated at 1, 3, 6, and 12 months after surgery using the International Prostate Symptom Score (IPSS), quality of life (QoL) score, peak urinary flow rate (Q _max), and postvoid residual urine volume (PVR). At baseline, mean age was 72.8 ± 6.8 years and mean prostate-specific antigen (PSA) level was 45.2 ± 26.9 ng/mL. The average energy consumed was 171.2 ± 72.3 kJ during a mean operative time of 46.3 ± 13.7 min. Mean catheterization duration was 3.3 ± 0.8 days. Mean hospitalization time was 5.2 ± 0.5 days. Compared with the preoperative values, there were significant continuous improvement in IPSS, QoL score, Q _max, and PVR at all time points of follow-up. The mean PSA nadir was 0.33 ± 0.15 ng/mL and the mean time to PSA nadir was 10.3 ± 2.5 months. Nine patients (23 %) eventually developed hormone refractory prostate cancer. No patient experienced severe intraoperative and postoperative complications. Our preliminary investigation shows that GreenLight HPS 120-W laser PVP is a safe and effective treatment for advanced PCa patients with AUR. Patients may obtain some oncological benefits from tumor cytoreduction by early palliative PVP.

Shao Q, Ouyang J, Fan Y, Xie J, Zhou J, Wu J, Karim KA, Xu J, Liu G, Shan Y, Wen D, Zhang Y (2012) Prostate cancer in the senior men from rural areas in east district of China: contemporary management and 5-year outcomes at multi-institutional collaboration. Cancer Lett 315(2):170–177PubMedCrossRef

Peyromaure M, Debre B, Mao K, Zhang G, Wang Y, Sun Z, Xu D, Jiang J, Sun Y (2005) Management of prostate cancer in China: a multicenter report of 6 institutions. J Urol 174(5):1794–1797PubMedCrossRef

Khafagy R, Shackley D, Samuel J, O'Flynn K, Betts C, Clarke N (2007) Complications arising in the final year of life in men dying from advanced prostate cancer. J Palliat Med 10(3):705–711PubMedCrossRef

Moul JW, Davis R, Vaccaro JA, Sihelnik SA, Belville WD, McLeod DG (1989) Acute urinary retention associated with prostatic carcinoma. J Urol 141(6):1375–1377PubMed

Liberale F, Muir GH, Walsh K, Krishnamoorthy R (2011) GreenLight laser prostatectomy: a safe and effective treatment for bladder outlet obstruction by prostate cancer. BJU Int 107(5):772–776PubMedCrossRef

Marszalek M, Ponholzer A, Rauchenwald M, Madersbacher S (2007) Palliative transurethral resection of the prostate: functional outcome and impact on survival. BJU Int 99(1):56–59PubMedCrossRef

Gnanapragasam VJ, Kumar V, Langton D, Pickard RS, Leung HY (2006) Outcome of transurethral prostatectomy for the palliative management of lower urinary tract symptoms in men with prostate cancer. Int J Urol 13(6):711–715PubMedCrossRef

Crain DS, Amling CL, Kane CJ (2004) Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer. J Urol 171(2 Pt 1):668–671PubMedCrossRef

Thomas DJ, Balaji VJ, Coptcoat MJ, Abercrombie GF (1992) Acute urinary retention secondary to carcinoma of the prostate. Is initial channel TURP beneficial? J R Soc Med 85(6):318–319PubMed

10.

Mazur AW, Thompson IM (1991) Efficacy and morbidity of "channel" TURP. Urology 38(6):526–528PubMedCrossRef

11.

Chang CC, Kuo JY, Chen KK, Lin AT, Chang YH, Wu HH, Chang LS (2006) Transurethral prostatic resection for acute urinary retention in patients with prostate cancer. J Chin Med Assoc 69(1):21–25PubMedCrossRef

12.

Heung YM, Walsh K, Sriprasad S, Mulvin D, Sherwood RA (2000) The detection of prostate cells by the reverse transcription-polymerase chain reaction in the circulation of patients undergoing transurethral resection of the prostate. BJU Int 85(1):65–69PubMedCrossRef

13.

Van Cleynenbreugel B, Srirangam SJ, Van Poppel H (2009) High-performance system GreenLight laser: indications and outcomes. Curr Opin Urol 19(1):33–37PubMedCrossRef

14.

Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M (2002) Prostate. In: American Joint Committee on Cancer: AJCC Cancer Staging Manual. 6th edition. New York, NY: Springer. pp 309–316

15.

Choueiri TK, Xie W, D'Amico AV, Ross RW, Hu JC, Pomerantz M, Regan MM, Taplin ME, Kantoff PW, Sartor O, Oh WK (2009) Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy. Cancer 115(5):981–987PubMedCrossRef

16.

Mommsen S, Petersen L (1994) Transurethral catheter removal after bilateral orchiectomy for prostatic carcinoma associated with acute urinary retention. Scand J Urol Nephrol 28(4):401–404PubMedCrossRef

17.

Klarskov LL, Klarskov P, Mommsen S, Svolgaard N (2012) Effect of endocrine treatment on voiding and prostate size in men with prostate cancer: a long-term prospective study. Scand J Urol Nephrol 46(1):37–43PubMedCrossRef

18.

Fleischmann JD, Catalona WJ (1985) Endocrine therapy for bladder outlet obstruction from carcinoma of the prostate. J Urol 134(3):498–500PubMed

19.

Varenhorst E, Alund G (1985) Urethral obstruction secondary to carcinoma of prostate: response to endocrine treatment. Urology 25(4):354–356PubMedCrossRef

20.

Madersbacher S, Marberger M (1999) Is transurethral resection of the prostate still justified. BJU Int 83(3):227–237PubMedCrossRef

21.

Hanks GE, Leibel S, Kramer S (1983) The dissemination of cancer by transurethral resection of locally advanced prostate cancer. J Urol 129(2):309–311PubMed

22.

Barber NJ, Muir GH (2004) High-power KTP laser prostatectomy: the new challenge to transurethral resection of the prostate. Curr Opin Urol 14(1):21–25PubMedCrossRef

23.

Malek RS, Barrett DM, Kuntzman RS (1998) High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 51(2):254–256PubMedCrossRef

24.

Spaliviero M, Araki M, Wong C (2008) Short-term outcomes of Greenlight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). J Endourol 22(10):2341–2347PubMedCrossRef

25.

De Nunzio C, Miano R, Trucchi A, Miano L, Franco G, Squillacciotti S, Tubaro A (2010) Photoselective prostatic vaporization for bladder outlet obstruction: 12-month evaluation of storage and voiding symptoms. J Urol 183(3):1098–1103PubMedCrossRef

26.

Lukacs B, Loeffler J, Bruyere F, Blanchet P, Gelet A, Coloby P, De la Taille A, Lemaire P, Baron JC, Cornu JN, Aout M, Rousseau H, Vicaut E (2012) Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol 61(6):1165–1173PubMedCrossRef

27.

Gu X, Strom K, Spaliviero M, Wong C (2012) Does prostate configuration affect the efficacy and safety of GreenLight HPS laser photoselective vaporization prostatectomy (PVP). Lasers Med Sci. doi:10.1007/s10103-012-1085-4

28.

Sehgal A, Mandhani A, Gupta N, Dubey D, Srivastava A, Kapoor R, Kumar A (2005) Can the need for palliative transurethral prostatic resection in patients with advanced carcinoma of the prostate be predicted. J Endourol 19(5):546–549PubMedCrossRef

29.

Qin XJ, Ma CG, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ, Zhu Y, Zhu YP, Shi GH, Xiao WJ, Lin GW, Swanson GP (2012) Tumor cytoreduction results in better response to androgen ablation—a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer. Urol Oncol 30(2):145–149PubMedCrossRef

Title: GreenLight HPS 120-W laser photoselective vaporization of the prostate as early therapy for acute urinary retention in advanced prostate cancer patients
Authors: Dong Chen
Boxin Xue
Yuxi Shan
Dongrong Yang
Chuanyang Sun
Jie Gao
Publication date: 01-09-2013
Publisher: Springer London
Published in: Lasers in Medical Science / Issue 5/2013
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-012-1252-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

GreenLight HPS 120-W laser photoselective vaporization of the prostate as early therapy for acute urinary retention in advanced prostate cancer patients

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2013

Low-level laser therapy (LLLT) combined with swimming training improved the lipid profile in rats fed with high-fat diet

Structural response of human corneal and scleral tissues to collagen cross-linking treatment with riboflavin and ultraviolet A light

Effect of laser therapy on skeletal muscle repair process in diabetic rats

Infrared low-level diode laser on inflammatory process modulation in mice: pro- and anti-inflammatory cytokines

Custom-made, selective laser sintering (SLS) blade implants as a non-conventional solution for the prosthetic rehabilitation of extremely atrophied posterior mandible

Er,Cr:YSGG laser influence on microleakage of class V composite resin restorations